Dual effect of neutrophils on pIgR/secretory component in human bronchial epithelial cells: Role of TGF-β

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Pilette, Charles ^a   Ratajczak, Céline ^a   Guisset, Amélie ^a   Detry, Bruno ^a   Sibille, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; SECRETORY COMPONENT; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; DEGRADATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL COUNT; SIGNAL TRANSDUCTION; UPREGULATION;

BRONCHI; CELL LINE; EPITHELIAL CELLS; HUMANS; NEUTROPHILS; OXIDATION-REDUCTION; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; RESPIRATORY MUCOSA; SECRETORY COMPONENT; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77955411465     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/428618     Document Type: Article

References (33)

1. Pilette C., Durham S. R., Vaerman J. P., Sibille Y., Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A? Proceedings of the American Thoracic Society 2004 1 2 125 135
2. Brandtzaeg P., Role of secretory antibodies in the defence against infections International Journal of Medical Microbiology 2003 293 1 3 15
3. Kaetzel C. S., The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces Immunological Reviews 2005 206 83 99
4. Mannino D. M., Buist A. S., Global burden of COPD: risk factors, prevalence, and future trends Lancet 2007 370 9589 765 773
5. Curtis J. L., Freeman C. M., Hogg J. C., The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research Proceedings of the American Thoracic Society 2007 4 7 512 521
6. Pilette C., Colinet B., Kiss R., Andr S., Kaltner H., Gabius H.-J., Delos M., Vaerman J.-P., Decramer M., Sibille Y., Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD European Respiratory Journal 2007 29 5 914 922
7. Pilette C., Godding V., Kiss R., Delos M., Verbeken E., Decaestecker C., De Paepe K., Vaerman J.-P., Decramer M., Sibille Y., Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2001 163 1 185 194
8. Pilette C., Ouadrhiri Y., Dimanche F., Vaerman J.-P., Sibille Y., Secretory component is cleaved by neutrophil serine proteinases but its epithelial production is increased by neutrophils through NF- B- and p38 mitogen-activated protein kinase-dependent mechanisms American Journal of Respiratory Cell and Molecular Biology 2003 28 4 485 498
9. Bruggisser R., Von Daeniken K., Jundt G., Schaffner W., Tullberg-Reinert H., Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay Planta Medica 2002 68 5 445 448
10. Keatings V. M., Barnes P. J., Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects American Journal of Respiratory and Critical Care Medicine 1997 155 2 449 453
11. Grotendorst G. R., Smale G., Pencev D., Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils Journal of Cellular Physiology 1989 140 2 396 402
12. Fava R. A., Olsen N. J., Postlethwaite A. E., Broadley K. N., Davidson J. M., Nanney L. B., Lucas C., Townes A. S., Transforming growth factor 1 (TGF- 1) induced neutrophil recruitment to synovial tissues: implications for TGF- -driven synovial inflammation and hyperplasia Journal of Experimental Medicine 1991 173 5 1121 1132
13. van Vlasselaer P., Punnonen J., De Vries J. E., Transforming growth factor- directs IgA switching in human B cells Journal of Immunology 1992 148 7 2062 2067
14. McIntyre T. M., Kehry M. R., Snapper C. M., Novel in vitro model for high-rate IgA class switching Journal of Immunology 1995 154 7 3156 3161
15. Sacco O., Romberger D., Rizzino A., Beckmann J. D., Rennard S. I., Spurzem J. R., Spontaneous production of transforming growth factor- 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro Journal of Clinical Investigation 1992 90 4 1379 1385
16. Wang R. D., Wright J. L., Churg A., Transforming growth factor-β1 drives airway remodeling in cigarette smoke-exposed tracheal explants American Journal of Respiratory Cell and Molecular Biology 2005 33 4 387 393
17. de Boer W. I., van Schadewijk A., Sont J. K., Sharma H. S., Stolk J., Hiemstra P. S., Van Krieken J. H. J. M., Transforming growth factorβ1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 1998 158 6 1951 1957
18. Takizawa H., Tanaka M., Takami K., Ohtoshi T., Ito K., Satoh M., Okada Y., Yamasawa F., Nakahara K., Umeda A., Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD) American Journal of Respiratory and Critical Care Medicine 2001 163 6 1476 1483
19. Luo B.-L., Niu R.-C., Feng J.-T., Hu C.-P., Xie X.-Y., Ma L.-J., Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-β/Smads signaling pathways Archives of Medical Research 2008 39 4 388 396
20. Sullivan A. L., Dafforn T., Hiemstra P. S., Stockley R. A., Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex Respiratory research 2008 9 60
21. Sethi J. M., Rochester C. L., Smoking and chronic obstructive pulmonary disease Clinics in Chest Medicine 2000 21 1 67 86
22. Rahman I., Adcock I. M., Oxidative stress and redox regulation of lung inflammation in COPD European Respiratory Journal 2006 28 1 219 242
23. Kinnula V. L., Chang L., Everitt J. I., Crapo J. D., Oxidants and antioxidants in alveolar epithelial type II cells: In situ, freshly isolated, and cultured cells American Journal of Physiology-Lung Cellular and Molecular Physiology 1992 262 1 L69 L77
24. Kinnula V. L., Chang L. Y., Ho Y. S., Crapo J. D., Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo Experimental Lung Research 1992 18 5 655 673
25. Jaspers I., Samet J. M., Erzurum S., Reed W., Vanadium-induced B-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase American Journal of Respiratory Cell and Molecular Biology 2000 23 1 95 102
26. Xiao Y. Q., Freire-de-Lima C. G., Janssen W. J., Morimoto K., Lyu D., Bratton D. L., Henson P. M., Oxidants selectively reverse TGF- suppression of proinflammatory mediator production Journal of Immunology 2006 176 2 1209 1217
27. Taggart C. C., Cryan S.-A., Weldon S., Gibbons A., Greene C. M., Kelly E., Low T. B., O'Neill S. J., McElvaney N. G., Secretory leucoprotease inhibitor binds to NF- B binding sites in monocytes and inhibits p65 binding Journal of Experimental Medicine 2005 202 12 1659 1668
28. Adcock I. M., Caramori G., Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next generation of drugs for severe asthma and COPD? BioDrugs 2004 18 3 167 180
29. Renda T., Baraldo S., Pelaia G., Bazzan E., Turato G., Papi A., Maestrelli P., Maselli R., Vatrella A., Fabbri L. M., Zuin R., Marsico S. A., Saetta M., Increased activation of p38 MAPK in COPD European Respiratory Journal 2008 31 1 62 69
30. Barnes P. J., Novel signal transduction modulators for the treatment of airway diseases Pharmacology and Therapeutics 2006 109 1-2 238 245
31. Underwood D. C., Osborn R. R., Bochnowicz S., Webb E. F., Rieman D. J., Lee J. C., Romanic A. M., Adams J. L., Hay D. W. P., Griswold D. E., SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung American Journal of Physiology 2000 279 5 L895 L902
32. Sallenave J.-M., The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease Respiratory Research 2000 1 2 87 92
33. Pfundt R., Wingens M., Bergers M., Zweers M., Frenken M., Schalkwijk J., TNF- and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway Archives of Dermatological Research 2000 292 4 180 187